Erick Denamur
Erick Denamur is an expert in Infectiology at Assistance Publique - Hôpitaux de Paris (France). Erick Denamur has authored 369 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 1,203 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Genetics
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1989 - 2026
Number : 369
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Escherichia coli ST131 isolates are rare in human meningitis but belong to a distinct O25b-fimH22 clade B lineage shared with avian pathogenic Escherichia coli. PMID 42841873 — escherichia, genomics, infant, newborn, poultry, genome, meningitis, food, phylogeny, escherichia coli, virulence | Microb Genom | 2026 | 0 |
| Prevalence and risk factors for persistent faecal carriage of extended spectrum beta-lactamase producing Escherichia coli in a paediatric community population. PMID 42735555 — escherichia, tissue adhesions, genes, genome, carrier state, prevalence, escherichia coli, risk factors, beta-lactamases, clone cells, child, infant | Int J Med Microbiol | 2026 | 0 |
| Influence of iron uptake systems on cefiderocol activity in Escherichia coli: At the crossroads of antibiotic resistance and virulence. PMID 42429791 — escherichia, genome, drug therapy, escherichia coli, operon, virulence, anti-bacterial agents, antiviral agents | Antimicrob Agents Chemother | 2026 | 0 |
| Effects of septic shock vasopressors on the fitness of Escherichia coli. PMID 42203850 — escherichia, genetic variation, serum, norepinephrine, shock, septic, angiotensins, sepsis, escherichia coli, natural science disciplines, virulence | Sci Rep | 2026 | 0 |
| Phage-steering permits antibody-mediated clearance of E. coli K1 from the gut. PMID 41876525 — mothers, vaccines, vaccination, bacteriophages, capsules, escherichia coli, o antigens | Nat Commun | 2026 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 3
LeadR Networks
Main global connection map